Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2469-2475

  Kuji, Tadashi ^a   Masaki, Takahisa ^a   Li, Li ^a   Cheung, Alfred K ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Haemodialysis; Myointimal hyperplasia; Synthetic graft; Vascular access; Vascular smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BROXURIDINE; C REACTIVE PROTEIN; MESSENGER RNA; POLITEF;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS SHUNT; ARTERY GRAFT; ARTICLE; BLOOD VESSEL SHUNT; CAROTID ARTERY; CELL CULTURE; CELL HYPERPLASIA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DATA ANALYSIS; GENE EXPRESSION; HEMODIALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INCUBATION TIME; INTIMA; JUGULAR VEIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLITEF IMPLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR ACCESS; VASCULAR SMOOTH MUSCLE; VEIN GRAFT;

ACTINS; ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; C-REACTIVE PROTEIN; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MUSCLE, SMOOTH, VASCULAR; POLYTETRAFLUOROETHYLENE; RNA, MESSENGER; SWINE; TUNICA INTIMA;

EID: 34548448133     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm240     Document Type: Article

References (20)

1. Roy-Chaudhury P, Kelly BS, Miller MA et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-2334
2. Yasojima K, Schwab C, McGeer EG et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158: 1039-1051
3. Anty R, Bekri S, Luciani N et al. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes and NASH. Am J Gastroenterol 2006; 101: 1824-1833
4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143
5. Jabs WJ, Theissing E, Nitschke M et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003; 108: 1428-1431
6. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930-1932
7. Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003; 58: 186-195
8. Rotmans JI, Velema E, Verhagen HJ et al. Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine, bilateral, carotid arteriovenous graft model. J Surg Res 2003; 113: 161-171
9. Parra MD, Fuentes P, Tecles F et al. Porcine acute phase protein concentrations in different diseases in field conditions. J Vet Med B Infect Dis Yet Public Health 2006; 53: 488-493.
10. Tecles F, Fuentes P, Martinez SS et al. Analytical validation of commercially available methods for acute phase proteins quantification in pigs. Res Vet Sci 2006 [Epub ahead of print]
11. Stevenson LS, McCullough K, Vincent I et al. Cytokine and C-reactive protein profiles induced by porcine circovirus type 2 experimental infection in 3 week old piglets. Viral Immunol 2006; 19: 189-195
12. Turk JR, Carroll JA, Laughlin MH et al. C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs. J Appl Physiol 2003; 95: 1301-1304
13. Kuji T, Masaki T, Goteti K et al. Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney Int 2006; 69: 2179-2085
14. Zhu W, Masaki T, Cheung AK et al. Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells. Biochem Pharmacol 2006; 72: 956-964
15. Masaki T, Rathi R, Zentner G et al. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int 2004; 66: 2061-2069
16. Wigmore SJ, Fearon KC, Maingay JP et al. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 1997; 273: E720-E726
17. Blaschke F, Bruemmer D, Yin F et al. C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation 2004; 110: 579-587
18. Wang CH, Li SH, Weisel RD et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783-1790
19. Swafford AN,Jr., Bratz IN, Knudson JD et al. C-reactive protein does not relax vascular smooth muscle: Effects mediated by sodium azide in commercially available preparations. Am J Physiol Heart Circ Physiol 2005; 288: H1786-H1795
20. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006; 24: 33-50